Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $25,091 | 11 | 93.6% |
| Food and Beverage | $1,689 | 107 | 6.3% |
| Education | $24.21 | 2 | 0.1% |
| Unspecified | $0 | 1 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| QT Imaging, Inc. | $25,257 | 13 | $0 (2022) |
| Amgen Inc. | $228.07 | 15 | $0 (2020) |
| Celgene Corporation | $138.07 | 9 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $112.99 | 8 | $0 (2019) |
| Janssen Biotech, Inc. | $98.56 | 7 | $0 (2020) |
| Bayer HealthCare Pharmaceuticals Inc. | $95.54 | 7 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $80.86 | 6 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $74.12 | 5 | $0 (2019) |
| EISAI INC. | $68.08 | 5 | $0 (2019) |
| Pharmacyclics LLC, An AbbVie Company | $66.35 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $24.12 | 1 | Novocure Inc. ($24.12) |
| 2022 | $10,455 | 7 | QT Imaging, Inc. ($10,455) |
| 2021 | $14,636 | 5 | QT Imaging, Inc. ($14,636) |
| 2020 | $285.34 | 8 | QT Imaging, Inc. ($166.55) |
| 2019 | $708.69 | 49 | Amgen Inc. ($104.51) |
| 2018 | $383.29 | 28 | Novartis Pharmaceuticals Corporation ($56.70) |
| 2017 | $312.21 | 23 | Amgen Inc. ($51.66) |
All Payment Transactions
121 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $24.12 | General |
| Category: Oncology | ||||||
| 09/01/2022 | QT Imaging, Inc. | QT Scanner Model 2000A (Device) | Consulting Fee | Dividend, profit or other return on investment | $2,454.61 | General |
| Category: Mammography | ||||||
| 06/01/2022 | QT Imaging, Inc. | QT Scanner Model 2000A (Device) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Mammography | ||||||
| 04/01/2022 | QT Imaging, Inc. | QT Scanner Model 2000A (Device) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Mammography | ||||||
| 03/16/2022 | QT Imaging, Inc. | QT Scanner Model 2000A (Device) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Mammography | ||||||
| 02/01/2022 | QT Imaging, Inc. | QT Scanner Model 2000A (Device) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: Mammography | ||||||
| 01/13/2022 | QT Imaging, Inc. | QT Scanner Model 2000A (Device) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: Mammography | ||||||
| 2022 | QT Imaging, Inc. | — | — | — | $0.00 | Ownership |
| 12/01/2021 | QT Imaging, Inc. | QT Scanner Model 2000A (Device) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: Mammography | ||||||
| 11/01/2021 | QT Imaging, Inc. | QT Scanner Model 2000A (Device) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: Mammography | ||||||
| 10/01/2021 | QT Imaging, Inc. | QT Scanner Model 2000A (Device) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: Mammography | ||||||
| 09/09/2021 | QT Imaging, Inc. | QT Scanner Model 2000A (Device) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: Mammography | ||||||
| 08/01/2021 | QT Imaging, Inc. | QT Scanner Model 2000A (Device) | Consulting Fee | Dividend, profit or other return on investment | $4,636.00 | General |
| Category: Mammography | ||||||
| 03/02/2020 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug), Nubeqa | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Oncology | ||||||
| 02/26/2020 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA | Food and Beverage | In-kind items and services | $11.70 | General |
| Category: Oncology | ||||||
| 02/19/2020 | Amgen Inc. | Blincyto (Biological) | Food and Beverage | In-kind items and services | $30.68 | General |
| Category: Oncology | ||||||
| 02/18/2020 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $12.83 | General |
| Category: Oncology | ||||||
| 02/15/2020 | QT Imaging, Inc. | QT Scanner Model 2000A (Device) | Food and Beverage | In-kind items and services | $166.55 | General |
| Category: Mammography | ||||||
| 01/14/2020 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: Oncology | ||||||
| 01/10/2020 | Janssen Biotech, Inc. | IMBRUVICA (Drug), DARZALEX | Food and Beverage | In-kind items and services | $11.75 | General |
| Category: Oncology | ||||||
| 01/07/2020 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug), Nubeqa | Food and Beverage | In-kind items and services | $12.58 | General |
| Category: Oncology | ||||||
| 12/18/2019 | Amgen Inc. | KANJINTI (Biological), Nplate, XGEVA | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Oncology | ||||||
| 12/16/2019 | PORTOLA PHARMACEUTICALS, INC. | ANDEXXA (Biological) | Food and Beverage | Cash or cash equivalent | $13.39 | General |
| Category: HEMATOLOGY/NEUROLOGY | ||||||
| 12/12/2019 | Novocure Inc. | Oncology (Device) | Food and Beverage | Cash or cash equivalent | $7.62 | General |
| Category: Optune | ||||||
| 12/09/2019 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 338 | 856 | $209,496 | $57,293 |
| 2022 | 19 | 796 | 2,069 | $476,041 | $142,336 |
| 2021 | 18 | 777 | 2,141 | $467,493 | $137,611 |
| 2020 | 18 | 785 | 2,125 | $459,675 | $132,367 |
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77014 | Ct guidance for insertion of radiation therapy fields | Facility | 2023 | 44 | 349 | $42,409 | $11,979 | 28.2% |
| 77427 | Radiation treatment management, 5 treatment sessions | Facility | 2023 | 36 | 76 | $39,357 | $10,402 | 26.4% |
| 77301 | High precision radiation therapy planning | Facility | 2023 | 18 | 19 | $22,255 | $6,138 | 27.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 45 | 57 | $14,706 | $4,004 | 27.2% |
| 77334 | Design and construction of complex radiation treatment device | Facility | 2023 | 30 | 85 | $14,159 | $3,978 | 28.1% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Facility | 2023 | 19 | 22 | $13,614 | $3,844 | 28.2% |
| 77263 | Complex radiation therapy planning | Facility | 2023 | 27 | 30 | $13,884 | $3,600 | 25.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 27 | 27 | $13,805 | $3,399 | 24.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 25 | 28 | $9,716 | $2,859 | 29.4% |
| 77300 | Calculation of radiation therapy dose | Facility | 2023 | 26 | 113 | $10,057 | $2,822 | 28.1% |
| 77295 | 3d radiation therapy planning | Facility | 2023 | 11 | 12 | $7,355 | $2,062 | 28.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 19 | 24 | $4,176 | $1,151 | 27.6% |
| 77470 | Special radiation treatment | Facility | 2023 | 11 | 14 | $4,003 | $1,055 | 26.4% |
| 77427 | Radiation treatment management, 5 treatment sessions | Facility | 2022 | 64 | 237 | $107,124 | $34,285 | 32.0% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Facility | 2022 | 61 | 673 | $73,357 | $23,328 | 31.8% |
| 77301 | High precision radiation therapy planning | Facility | 2022 | 39 | 47 | $47,893 | $15,314 | 32.0% |
| 77263 | Complex radiation therapy planning | Facility | 2022 | 67 | 70 | $28,280 | $9,050 | 32.0% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Facility | 2022 | 41 | 51 | $27,948 | $8,929 | 31.9% |
| 77334 | Design and construction of complex radiation treatment device | Facility | 2022 | 66 | 181 | $26,607 | $8,468 | 31.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 52 | 52 | $25,636 | $7,077 | 27.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 77 | 97 | $25,026 | $6,846 | 27.4% |
| 77300 | Calculation of radiation therapy dose | Facility | 2022 | 66 | 247 | $19,513 | $6,250 | 32.0% |
| 77295 | 3d radiation therapy planning | Facility | 2022 | 30 | 34 | $18,632 | $5,928 | 31.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 72 | 85 | $14,790 | $3,889 | 26.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 24 | 28 | $9,716 | $2,671 | 27.5% |
About Dr. Kevin Mcmullen, MD
Dr. Kevin Mcmullen, MD is a Radiation Oncology healthcare provider based in Statesville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1093797045.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kevin Mcmullen, MD has received a total of $26,804 in payments from pharmaceutical and medical device companies, with $24.12 received in 2024. These payments were reported across 121 transactions from 30 companies. The most common payment nature is "Consulting Fee" ($25,091).
As a Medicare-enrolled provider, Mcmullen has provided services to 2,696 Medicare beneficiaries, totaling 7,191 services with total Medicare billing of $469,607. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Practice Information
- Specialty Radiation Oncology
- Location Statesville, NC
- Active Since 11/16/2005
- Last Updated 12/11/2024
- Taxonomy Code 2085R0001X
- Entity Type Individual
- NPI Number 1093797045
Products in Payments
- QT Scanner Model 2000A (Device) $25,257
- Neulasta (Biological) $92.02
- Xofigo (Drug) $78.27
- Revlimid (Drug) $74.82
- Lenvima (Drug) $68.08
- Imbruvica (Drug) $66.35
- Abraxane (Drug) $63.25
- MEKINIST (Drug) $59.71
- Rubraca (Drug) $57.35
- GILOTRIF (Drug) $50.31
- JAKAFI (Drug) $46.36
- IMBRUVICA (Drug) $46.11
- JADENU (Drug) $42.78
- DARZALEX (Biological) $41.12
- ZOLADEX (Drug) $40.04
- OPDIVO (Biological) $38.91
- LYNPARZA (Drug) $36.74
- INJECTAFER (Drug) $33.23
- JEVTANA (Drug) $31.97
- Blincyto (Biological) $30.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.